Physician profile
Daniel J Caruso
NPI 1144481615
$43,596.60
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $525 · 2021: $169 · 2022: $38K · 2023: $101 · 2024: $4,746 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $589 · Travel and Lodging: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $589.17 |
| Travel and Lodging | $415.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $41,966.06 | 2021-2024 | |
| Boston Scientific Corporation | $390.31 | 2020-2025 | Axonics |
| Endo Pharmaceuticals INC. | $337.57 | 2019-2023 | Xiaflex, Aveed |
| Medtronic USA, INC. | $262.54 | 2019-2020 | |
| Neotract INC. | $141.45 | 2019-2020 | |
| Olympus America INC. | $116.83 | 2024 | Soltive |
| Coloplast Corp | $102.88 | 2020-2025 | |
| Medtronic, INC. | $81.08 | 2023 | Interstim |
| Astellas Pharma US INC | $69.99 | 2021 | |
| Axonics, INC. | $65.19 | 2022-2024 | Axonics |
| Procept Biorobotics Corporation | $44.32 | 2024-2025 | Aquabeam System |
| Tolmar, INC. | $18.38 | 2025 | Jatenzo, Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Caruso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.